The DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Gender differences in the effects of cardiovascular drugs
Open accessAbstract
Although sex-specific differences in cardiovascular medicine are well known, the exact influences of sex on the effect of cardiovascular drugs remain unclear. Women and men differ in body composition and physiology (hormonal influences during the menstrual cycle, menopause, and pregnancy) and they present differences in drug pharmacokinetics (absorption, distribution, metabolism, and excretion) and pharmacodynamics, so that is not rare that they may respond differently to cardiovascular drugs. Furthermore, women are also less often treated with evidence-based drugs thereby preventing optimization of therapeutics for women of all ages, experience more relevant adverse drug reactions than men, and remain underrepresented in most clinical trials. Thus, current guidelines for prevention, diagnosis, and medical treatment for cardiovascular diseases are based on trials conducted predominantly in middle-aged men. A better understanding of these sex-related differences is fundamental to improve the safety and efficacy of cardiovascular drugs and for developing proper individualized cardiovascular therapeutic strategies both in men and women. This review briefly summarizes gender differences in the pharmacokinetics and pharmacodynamics of cardiovascular drugs and provides recommendations to close the gaps in our understanding of sex-specific differences in drug efficacy and safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–290 of 290
Kjeldsen, S. E., Kolloch, R. E., Leonetti, G., Malliond, J.-M., Zanchetti, A., Elmfeldt, D., Warnold, I., & Hansson, L. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018050-00017 · Cited by 116
Adverse effects in women: implications for drug development and regulatory policies
Parekh, A., Fadiran, E. O., Uhl, K., & Throckmorton, D. C. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.29 · Cited by 114
Gender and interindividual variability in pharmacokinetics
Nicolas, J.-M., Espié, P., & Molimard, M. (2009) · Drug Metabolism Reviews · doi:10.1080/10837450902891485 · Cited by 114
Gender Disparities in the Quality of Cardiovascular Disease Care in Private Managed Care Plans
Chou, A. F., Scholle, S. H., Weisman, C. S., Bierman, A. S., Correa‐de‐Araujo, R., & Mosca, L. J. (2007) · Women s Health Issues · doi:10.1016/j.whi.2007.03.002 · Cited by 113
Estrogen improves endothelial function
Arora, S., Veves, A., Caballaro, A. E., Smakowski, P., & LoGerfo, F. W. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70016-3 · Cited by 111
Samad, Z. Z., Boyle, S., Ersbøll, M. K., Vora, A. N., Zhang, Y., Becker, R. C., Williams, R. B., Kuhn, C. M., Ortel, T. L., Rogers, J. G., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.087 · Cited by 106
Karmali, K. N., Lloyd‐Jones, D. M., Berendsen, M. A., Goff, D. C., Sanghavi, D. M., Brown, N. C., Korenovska, L., & Huffman, M. D. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0218 · Cited by 106
Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban
Frost, C. E., Song, Y. J., Shenker, A., Wang, J. J. J., Barrett, Y. C., Schuster, A. E., Harris, S. I., & LaCreta, F. P. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0228-0 · Cited by 105
Statin induced diabetes and its clinical implications
Aiman, U., Najmi, A., & Khan, R. A. (2014) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.136097 · Cited by 105
Management of patients with heart failure in clinical practice: differences between men and women
Lenzen, M. J., Rosengren, A., Reimer, W. J. M. S. O., Folláth, F., Boersma, E. H., Simoons, M. L., Cleland, J. G. F., & Michel Komajda, N. (2007) · Heart · doi:10.1136/hrt.2006.099523 · Cited by 104
Yancy, C. W., Fonarow, G. C., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., McBride, M. L., Mehra, M. R., O’Connor, C. M., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.016 · Cited by 104
Race and sex influence clearance of nifedipine: Results of a population study
KRECICSHEPARD, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108678 · Cited by 104
Gomberg‐Maitland, M., WENGER, N. K., Feyzi, J. M., Lengyel, M., Volgman, A. S., Petersen, P., Frison, L., & Halperin, J. L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl103 · Cited by 102
Leizorovicz, A., Lechat, P. P., Cucherat, M., & Bugnard, F. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120768 · Cited by 101
Patti, G., Caterina, R. D., Abbate, R., Andreotti, F., Biasucci, L. M., Calabrò, P., Cioni, G., Davì, G., Sciascio, G. D., Golia, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu279 · Cited by 101
Kam, K. W. L., Qi, J. S., Chen, M., & Wong, T. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058339 · Cited by 100
Female sex as an important determinant of lisinopril-induced cough
Os, I., Bratland, B., Dahlöf, B., Gisholt, K., Syvertsen, J. O., & Tretli, S. (1992) · The Lancet · doi:10.1016/0140-6736(92)91694-4 · Cited by 95
The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites.
Ho, P. C., TRIGGS, E. J., Bourne, D. W. A., & Heazlewood, V. J. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02695.x · Cited by 95
The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group
(1981) · JAMA · doi:10.1001/jama.246.18.2073 · Cited by 95
VALsartan In Acute Myocardial Infarction (VALIANT) Trial: Baseline Characteristics in Context
Velazquez, E. J., Pfeffer, M. A., McMurray, J. J. V., Maggioni, A. P., Rouleau, J. L., de Werf, F. V., Køber, L., White, H. D., Swedberg, K. B., Leimberger, J. D., et al. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00112-0 · Cited by 94
Upregulation of β1-adrenergic receptors in ovariectomized rat hearts
Thawornkaiwong, A., Preawnim, S., & Wattanapermpool, J. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02473-6 · Cited by 93
Xie, M., Shan, Z., Zhang, Y., Chen, S., Yang, W., Bao, W., Rong, Y., Yu, X., Hu, F. B., & Liu, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090286 · Cited by 92
Sex Differences in Drug Effects: Interaction with Sex Hormones in Adult Life
Spoletini, I., Vitale, C., Malorni, W., & Rosano, G. M. C. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_5 · Cited by 90
Self-citationReduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9
Stein, E. A., & Raal, F. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-022613-090402 · Cited by 89
Husted, S., James, S. K., Bach, R. G., Becker, R. C., Budaj, A., Heras, M., Himmelmänn, A., Horrow, J. C., Katus, H. A., Lassila, R., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu075 · Cited by 88
Lansky, A. J., Mehran, R., Cristea, E., Parise, H., Feit, F., Ohman, E. M., White, H. D., Alexander, K. P., Bertrand, M. E., Desmet, W. J., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.030 · Cited by 88
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
Moretti, M. E., Caprara, D., Drehuta, I., Yeung, E., Cheung, S., Federico, L. M., & Koren, G. (2011) · Obstetrics and Gynecology International · doi:10.1155/2012/658310 · Cited by 86
Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes
Kurokawa, J., Kodama, M., Clancy, C. E., & Furukawa, T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.004 · Cited by 86
Miners, J. O., Grgurinovich, N., Whitehead, A., Robson, R., & Birkett, D. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb05240.x · Cited by 85
Effect of food on the absorption of enteric-coated aspirin: Correlation with gastric residence time
Mojaverian, P., Rocci, M. L., Conner, D. P., Abrams, W. B., & Vlasses, P. H. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.3 · Cited by 85
Wrishko, R. E., Ernest, C. S., Small, D. S., Li, Y. G., Weerakkody, G. J., Riesmeyer, J., Macias, W. L., Rohatagi, S., Salazar, D. E., Antman, E. M., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337942 · Cited by 84
Impact of race and gender on antithrombotic therapy
Capodanno, D., & Angiolillo, D. J. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-04-0232 · Cited by 83
KRECICSHEPARD, M., Barnas, C. R., Slimko, J., & Schwartz, J. B. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109356 · Cited by 80
Gender disparity in cardiac electrophysiology: Implications for cardiac safety pharmacology
Jonsson, M. K. B., Vos, M. A., Duker, G., Demolombe, S., & van Veen, T. A. B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.002 · Cited by 78
Walle, T., Byington, R. P., Furberg, C. D., McIntyre, K. M., & Vokonas, P. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.216 · Cited by 78
Ljungman, C. E. A., Kahan, T., Schiöler, L., Hjerpe, P., Hasselström, J., Wettermark, B., Boström, K. B., & Manhem, K. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.08.015 · Cited by 76
Subgroup Interactions in the Heart and Estrogen/Progestin Replacement Study: Lessons Learned
Furberg, C. D., Vittinghoff, E., Davidson, M., Herrington, D. M., Simon, J. A., WENGER, N. K., & Hulley, S. B. (2002) · Circulation · doi:10.1161/hc0802.104280 · Cited by 74
Reynolds, H. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.19.2054 · Cited by 74
Women's health research: progress, pitfalls, and promise
(2011) · Choice Reviews Online · doi:10.5860/choice.48-6314 · Cited by 74
Cough and angiotensin II receptor antagonists: cause or confounding?
Mackay, Pearce, N. E., & Mann (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00855.x · Cited by 73
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers
Walfisch, A., Al-Maawali, A. A., Moretti, M. E., Nickel, C., & Koren, G. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.579197 · Cited by 72
Alotaibi, G., Almodaimegh, H., McMurtry, M. S., & Wu, C. M. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.017 · Cited by 71
Jiang, J., Hu, Y., Zhang, J., Yang, J., Mueck, W., Kubitza, D., Bauer, R., Meng, L., & Hu, P. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0196 · Cited by 71
Chandrasekhar, J., Baber, U., Sartori, S., Faggioni, M., Aquino, M. B., Kini, A. S., Weintraub, W. S., Rao, S. V., Kapadia, S. R., Weiss, S. A., et al. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26606 · Cited by 70
Effects of hormone replacement therapy on QT interval
Larsen, J. A., Tung, R. H., Sadananda, R., Goldberger, J. J., Horvath, G., Parker, M. A., & Kadish, A. H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00523-2 · Cited by 67
Johnson, S. M., Karvonen, C. A., Phelps, C. L., et al. (2003) · Journal of Women s Health · doi:10.1089/154099903766651577 · Cited by 66
Gender Is an Important Determinant of the Disposition of the Loop Diuretic Torasemide
Werner, U., Werner, D., Heinbüchner, S., Graf, B., İnce, H., Kische, S., Thürmann, P., König, J., Fromm, M. F., & Zolk, O. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337514 · Cited by 66
Sex and Gender Differences in Cardiovascular Drug Therapy
Seeland, U., & Regitz‐Zagrosek, V. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_11 · Cited by 65
Adverse Drug Reactions in Women's Health Care
Tharpe, N. (2011) · Journal of Midwifery & Women's Health · doi:10.1111/j.1542-2011.2010.00050.x · Cited by 64
Drug-induced long QT syndrome in women: Review of current evidence and remaining gaps
Hreiche, R., Morissette, P., & Turgeon, J. (2008) · Gender Medicine · doi:10.1016/j.genm.2008.05.005 · Cited by 63
Statin Treatment, New-Onset Diabetes, and Other Adverse Effects: A Systematic Review
Bang, C. N., & Okin, P. M. (2014) · Current Cardiology Reports · doi:10.1007/s11886-013-0461-4 · Cited by 61
Gender Aspects in Cardiovascular Pharmacology
Oertelt‐Prigione, S., & Regitz‐Zagrosek, V. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9114-9 · Cited by 61
The Mechanism of Action of LCZ696
Menéndez, J. L. T. (2016) · Cardiac failure review · doi:10.15420/cfr.2016:1:1 · Cited by 59
Vinereanu, D., Stevens, S. R., Alexander, J. H., Al‐Khatib, S. M., Avezum, Á., Bahit, M. C., Granger, C. B., Lópes, R. D., Halvorsen, S., Hanna, M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv447 · Cited by 56
Self-citationGender Differences in Cardiovascular Drugs
Stolarz, A. J., & Rusch, N. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6611-8 · Cited by 54
Oldgren, J., Wallentin, L. C., Afzal, R., Bassand, J., Budaj, A., Chrolavicius, S., Fox, K. A. A., Granger, C. B., Mehta, S., Pais, P. S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm578 · Cited by 54
Population analyses of sustained‐release verapamil in patients: Effects of sex, race, and smoking
Kang, D., Verotta, D., KRECICSHEPARD, M., Modi, N. B., Gupta, S., & Schwartz, J. B. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.21 · Cited by 54
Ernest, C. S., Small, D. S., Rohatagi, S., Salazar, D. E., Wallentin, L. C., Winters, K. J., & Wrishko, R. E. (2008) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-008-9103-7 · Cited by 53
Mega, J. L., Morrow, D. A., Östör, E., Dorobanţu, M., Qin, J., Antman, E. M., & D, E. B. M. (2007) · Circulation · doi:10.1161/circulationaha.106.679548 · Cited by 53
Enriquez, J. R., Pratap, P., Zbilut, J. P., Calvin, J. E., & Volgman, A. S. (2008) · Gender Medicine · doi:10.1016/s1550-8579(08)80008-3 · Cited by 52
Metoprolol pharmacokinetics and the oral contraceptive pill.
Kendall, M. J., Quarterman, C., Jack, D. B., et al. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb04948.x · Cited by 52
The Influence of Gender on Arrhythmias
Peters, R. W., & Gold, M. R. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000096416.94304.bd · Cited by 51
The influence of gender on the effects of aspirin in preventing myocardial infarction
Yerman, T., Gan, W., & Sin, D. D. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-29 · Cited by 51
The effect of gender on the pharmacokinetics of verapamil and norverapamil in human
Dadashzadeh, S., Javadian, B., & Sadeghian, S. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.512 · Cited by 51
Hyponatraemia and hypokalaemia due to indapamide
Chapman, M., Hanrahan, R., McEwen, J., & Marley, J. E. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04377.x · Cited by 48
Gan, L., Langenickel, T., Petruck, J., Kode, K., Rajman, I., Chandra, P., Zhou, W., Rebello, S. S., & Sunkara, G. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.571 · Cited by 47
The Effect of Gender on Outcome in Digitalis-Treated Heart Failure Patients
Domański, M., Fleg, J. L., Bristow, M. R., & Knox, S. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.07.002 · Cited by 47
Fletcher, A. E., Beevers, D. G., Bulpitt, C. J., Ag, B., Coles, E. C., Hunt, D. U., Munro-Faure, A. D., Newson, R. B., Riordan, P. W. O., & Petrie, J. C. (1988) · PubMed · Cited by 47
Gender and the heart: sex-specific differences in normal anatomy and physiology.
Legato, M. J. (2000) · PubMed · Cited by 46
Sex Difference in the Antiplatelet Effect of Aspirin in Patients with Stroke
Cavallari, L. H., Helgason, C. M., Brace, L. D., Viana, M. A. G., & Nutescu, E. A. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g569 · Cited by 45
Chacko, M., Lincoff, A. M., Wolski, K. E., Cohen, D. J., Bittl, J. A., Lansky, A. J., Tsuchiya, Y., Betriu, A., Yen, M. H., Chew, D. P., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.02.012 · Cited by 44
Pradhan, A. D., Lewis, C. E., Manson, J. E., Rossouw, J. E., Hendrix, S. L., LaCroix, A. Z., Ridker, P. M., & Langer, R. D. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-09-0608 · Cited by 38
MOEN, E. K., Asher, C. R., Miller, D. P., Weaver, W. D., White, H. D., Califf, R. M., & Topol, E. J. (1997) · Journal of Women s Health · doi:10.1089/jwh.1997.6.285 · Cited by 35
Efficacy of If Inhibition with Ivabradine in Different Subpopulations with Stable Angina Pectoris
Tendera, M., BORER, J. S., & Tardif, J. (2009) · Cardiology · doi:10.1159/000219938 · Cited by 34
Sex-related differences in platelet aggregation in native whole blood
Zwierzina, W. D., Kunz, F., Kogelnig, R., & Herold, M. (1987) · Thrombosis Research · doi:10.1016/0049-3848(87)90412-9 · Cited by 33
Gender‐Related Differences in Ventricular Repolarization: Beyond Gonadal Steroids
Arya, A. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.40845.x · Cited by 33
Zaccardi, F., Pitocco, D., Willeit, P., & Laukkanen, J. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.015 · Cited by 33
Wallach‐Kildemoes, H., Hendriksen, C., & Andersen, M. T. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2195 · Cited by 31
Monitoring Platelet Function to Reduce the Risk of Ischemic and Bleeding Complications
Price, M. J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.022 · Cited by 31
Sex, Digitalis, and the Sodium Pump
Blaustein, M. P., Robinson, S., Gottlieb, S. S., Balke, C. W., & Hamlyn, J. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.68 · Cited by 31
O’Donoghue, M. L., Bhatt, D. L., Stone, G. W., Steg, P. G., Gibson, C. M., Hamm, C. W., Price, M. J., Prats, J., Liu, T., Deliargyris, E., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017300 · Cited by 31
Loffredo, L., Violi, F., & Perri, L. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.086 · Cited by 31
Selection of Treatment Among Latina and Non-Latina White Women with Ductal Carcinoma in Situ
Kaplan, C. P., Nápoles, A. M., Hwang, E. S., Bloom, J. R., STEWART, S. L., Nickleach, D. C., & Karliner, L. (2010) · Journal of Women s Health · doi:10.1089/jwh.2010.1986 · Cited by 27
Cohen, M. C., Antman, E. M., Gurfinkel, E., & Radley, D. R. (2001) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1015259706522 · Cited by 21
Jarugula, V. R., Yeh, C., Howard, D., Bush, C. A., Keefe, D. L., & Dole, W. P. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009359525 · Cited by 21
Gender and Its Effect in Cardiovascular Pharmacotherapeutics: Recent Considerations
Sica, D. A., Wood, M. A., & Hess, M. (2005) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2005.04171.x · Cited by 20
Vree, T. B., Dammers, E., & Valducci, R. (2004) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42463 · Cited by 17
Sex-Related Differences in Heart Failure and Beta-Blockers
Ghali, J. K. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000046370.81174.94 · Cited by 16
Dziewierz, A., Siudak, Z., Rakowski, T., Kleczyński, P., Dubiel, J. S., & Dudek, D. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0826-3 · Cited by 14
Cooper, W. O. (2008) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000305052.73376.de · Cited by 14
Cited by
Sex differences in pharmacokinetics predict adverse drug reactions in women
Zucker, I., & Prendergast, B. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00308-5 · Cited by 777
Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
Regitz-Zagrosek, V., & Gebhard, C. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00797-4 · Cited by 386
Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants
Millett, E. R. C., Peters, S. A. E., & Woodward, M. (2018) · BMJ · doi:10.1136/bmj.k4247 · Cited by 364
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Metadata
- Authors
- Tamargo, J., Rosano, G., Walther, T., Duarte, J., Niessner, A., Kaski, J., Ceconi, C., Drexel, H., Kjeldsen, K., Savarese, G., Torp-Pedersen, C., Atar, D., Lewis, B., & Agewall, S.
- Venue
- European Heart Journal - Cardiovascular Pharmacotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-28
- Volume
- 3
- Issue
- 3
- Pages
- 163-182
- ISSN
- 2055-6837 (ISSN-L)
- 2055-6845
- OpenAlex
- W2592398938
- Cited by
- 317
- References
- 290
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.